In memory of John Jolley

A few months ago, we were informed that John Jolley had passed away. John was among the most active…

"E.I.P.G. is a European association representing the national, professional organizations of pharmacists
employed in the pharmaceutical or allied industries of the Member States of the European Union,
the European Economic Area, or European countries having a mutual recognition agreement
with the European Union on compliance control of regulated medicines."

Read More

Presentations

Our media library contains an extensive collection of presentations by EIPG Bureau members or delegates, and presentations made at Scientific Symposia.
Read More
Read More

Position Papers

EIPG issues comments and feedback in response to consultation documents and white papers released by the European Medicines Agency and the European Commission.
Read More
Read More

Education

EIPG’s initiatives dedicated to industrial pharmacist education, including the EU-funded projects MOGLYNET, PHAR-IN and PHARMINE.
Read More
Read More

Members’ Area

Member organisations can sign in here to get even more information regarding EIPG’s projects and works.
Read More

EMA guideline on investigational ATMPs

The guideline adopted by EMA’s CHMP Committee on 20 January 2025 will come into force on 1 July. It discusses in detail all the different aspects to be considered during the development of an investigational advanced therapy medicinal product, both in exploratory and confirmatory studies, in order to prepare a submission dossier adequate to support application for marketing authorisation
Read More

The proposal of a Critical Medicines Act

The Critical Medicines Act proposed by the European Commission aims to overcome supply issues and shortages of medicinal products by mean of the activation of Strategic Projects, new procurement requirements and improved international partnerships
Read More

The Clean Industrial Deal and the Omnibus package on simplification

The European Commission published the Clean Industrial Deal on 26 February 2025, detailing the strategy that should support the final transition to the new models based on decarbonisation, electrification, innovation and reindustrialisation of the European Union. The first two Omnibus packages of measures aimed to lower energy prices, simplify procedures for companies and improve the InvestEU regulation were also released and will now undergo examination by the EU Parliament and Council
Read More

The FDA’s Advanced Manufacturing Technologies Designation Program

The Advanced Manufacturing Technologies Designation Program aims to accelerate the implementation of novel manufacturing technologies and the application of existing ones to new contexts of use. The FDA Guidance for Industry, published at the beginning of January 2025, describes the entire process of submitting a request for AMT designation and its contents
Read More

The EU’s Competitiveness Compass and the new EU Biotech Hub

The Competitiveness Compass describes the new European Commission’s political actions to fill the gap with international competitors, support the transition to clean and digital technologies, and reduce supply chains’ dependencies in strategic sectors. Among these are also biotechnologies and more extensively, life sciences.
Read More